InvestorsHub Logo
Followers 62
Posts 3684
Boards Moderated 0
Alias Born 11/21/2018

Re: None

Sunday, 10/25/2020 8:35:12 PM

Sunday, October 25, 2020 8:35:12 PM

Post# of 44690
SamiAir is the first FDA-approved COVID-19 therapeutic that achieves a 3-fold improvement in survival and recovery from respiratory failure in COVID-19, compared to best-available ICU care. It blocks replication of coronavirus in lung cells, blocks inflammatory cytokines, prevents death of lung cells, and increases oxygen exchange with the blood.

https://edisonawards.com/nomineegallery2021.php